Community-acquired thoracic empyema in older people

Journal of the American Geriatrics Society

Volumn 53, Issue 7, 2005, Pages 1203-1209

  Tsai, Tzu Hsiu ^a   Jerng, Jih Shuin ^a   Chen, Kuan Yu ^a   Yu, Chong Jen ^a   Yang, Pan Chyr ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Community acquired; Elderly; Microbiology; Outcome; Thoracic empyema

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; BETA LACTAM; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN; CLINDAMYCIN; HEMOGLOBIN; METRONIDAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOKINASE; UROKINASE;

ADULT; AGED; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DYSPNEA; EMPYEMA; FEMALE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PATHOGENESIS; PLEURA FLUID; RETROSPECTIVE STUDY; REVIEW; STREPTOCOCCUS; THORAX DISEASE; THORAX DRAINAGE; THORAX PAIN; THORAX SURGERY; TREATMENT OUTCOME; ADOLESCENT; ARTICLE; COMMUNICABLE DISEASE; DISEASE TRANSMISSION; MICROBIOLOGY; MIDDLE AGED; PLEURA EMPYEMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMMUNITY-ACQUIRED INFECTIONS; EMPYEMA, PLEURAL; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 24344488635     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2005.53371.x     Document Type: Review

References (28)

1. Light RW, Girard WM, Jenkinson SG et al. Parapneumonic effusions. Am J Med 1980;69:507-512.
2. Maskell NA, Davies RJ. Effusions from parapneumonic infection and empyema. In: Light RW, Lee YC, eds. Textbook of Pleural Diseases. London: Arnold Publishers, 2003, pp 310-328.
3. Hamm H, Light RW. Parapneumonic effusion and empyema. Eur Respir J 1997;10:1150-1156.
4. Ferguson A, Precott R, Selkon J et al. The clinical course and management of thoracic empyema. QJM 1999;89:285-289.
5. Smith JA, Mullerworth MH, Westlake GW et al. Empyema thoracis: 14-year experience in a teaching center. Ann Thorac Surg 1991;51:39-42.
6. Alfgeme I, Munoz F, Pena N et al. Empyema of thorax in adults: Etiology, microbiologic findings and management. Chest 1993;103:839-843.
7. Lindstrom ST, Kolbe J, Community acquired parapneumonic thoracic empyema: Predictors of outcome. Respirology 1999;4:173-179.
8. Chen KY, Hsueh PR, Liaw YS et al. A 10-year experience with bacteriology of acute thoracic empyema. Chest 2000;117:1685-1689.
9. Greengross S, Murphy E, Quam L et al. Aging: A subject that must be at the top of world agendas. BMJ 1997;315:1029-1030.
10. Chan ED, Welsh CH. Geriatric respiratory medicine. Chest 1998;114:1704-1733.
11. Harper C, Newton P. Clinical aspects of pneumonia in the elderly veteran. J Am Geriatr Soc 1989;37:867-872.
12. Mandal AK, Thadepalli H, Mandal AK et al. outcome of primary empyema thoracis: Therapeutic and microbiologic aspects. Ann Thorac Surg 1998;66: 1782-1786.
13. Sahn SA. Use of fibrinolytic agents in the management of complicated parapneumonic effusion and empyemas. Thorax 1998;53(Suppl. 2):S65-S72.
14. Waller DA, Thoracoscopy in the management of postpneumonic pleural effusions. Curr Opin Pulm Med 2002;8:323-326.
15. Heffner JE, Brown LK, Barieri C et al. Pleural fluid chemical analysis in parapneumonic effusion, A meta-analysis. Am J Respir Crit Care Med 1995;151: 1700-1708.
16. Metlay JP, Schulz R, Li YH et al. Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med 1997;157: 1453-1459.
17. Starczewski AR, Allen SC, Vargas E et al. Clinical prognostic indices of fatality in elderly patients admitted to hospital with acute pneumonia. Age Ageing 1988;17:181-186.
18. Marrie TJ, Haldane EV, Faulkner RS et al. Community-acquired pneumonia requiring hospitalization: Is it different in the elderly. J Am Geriatr Soc 1985;33:671-680.
19. Bartlett JG. Anaerobic bacterial infections of the lung and pleural space. Clin Infect Dis 1993;16(Suppl 4):S248-S255.
20. Bartlett JG, Finegold SM. Anaerobic infections of the lung and pleural space. Am Rev Respir Dis 1974;110:56-77.
21. Hughe CE, Van Scoy RE. Antibiotic therapy of pleural empyema. Semin Respir Infect 1991;6:94-102.
22. Singer BH, Manton KG. The effects of health changes on projections of health service needs for the elderly population of the United States. Proc Natl Acad Sci USA 1998;95:15618-15622.
23. Davies CWH, Kearney SE, Fergus Vet al. Predictors of outcome and long-term survival in patients with pleural infection. Am J Respir Crit Care Med 1999;160:1682-1687.
24. Ulmer JL, Choplin RH, Reed JC. Image-guided catheter drainage of the infected pleural spaces. J Thorac Imaging 1991;6:65-73.
25. Cham CW, Haq SM, Rahamim J, Empyema thoracis: A problem with late referral? Thorax 1993;48:925-927.
26. Wait MA, Sharma S, Hohn J et al. A randomized trial of empyema therapy. Chest 1997;111:1548-1551.
27. Petrkis IE, Kogerakis NE, Drositis IE et al. Video-assisted thoracoscopic surgery for thoracic empyema: Primarily, or after fibrinolytic therapy failure? Am J Surg 2004;187:471-474.
28. Varkey B, Rose HD, Kesavan Kutty CP et al. Empyema thoracis during a ten year period: Analysis of 72 cases and comparison to a previous study (1952-67). Arch Intern Med 1981;141:1771-1776.